Skip to content(if available)orjump to list(if available)

Kyoto University team develops pain reliever comparable to morphine

burnt-resistor

A new class of selective α2B-adrenoceptor antagonist.

erickhill

Why is this written in such a way to only target cancer patients?

bitwize

The class of patients most likely to require opioids over long periods of time?

delusional

And a class disproportionately insensitive to long term negative side effects.

kelseyfrog

How is it different from Imiloxan?

petesergeant

Marginally more info, along with the title of the paper, but the doi is broken: https://medicalxpress.com/news/2025-08-discovery-analgesic-p...

There's also the alternative Journavx: https://en.wikipedia.org/wiki/Suzetrigine